Updates are available Correction dated 2025-09-08
Click to view Correction: https://doi.org/10.1007/s12028-025-02380-4
-
Authors
Blackburn, Spiros L. https://orcid.org/0000-0003-2902-5079
Babi, Marc A.
Grande, Andrew W.
Choudhri, Omar A.
Hauck, Erik F.
Kellner, Christopher P.
Giordano, Michael C.
Lad, Shivanand P.
McCabe, Aaron R.
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health (R44NS110247)
- License Information
-
More Information
Article History
Received: 2 January 2025
Accepted: 3 July 2025
First Online: 31 July 2025
Change Date: 7 September 2025
Change Type: Update
Change Details: The original online version of this article was revised due to a retrospective Open Access order.
Change Date: 8 September 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s12028-025-02380-4
Declarations
:
: Dr. Blackburn, Dr. Babi, Dr. Grande, and Dr. Hauck have no disclosures. Dr. Omar Choudhri is consultant for Medtronic neurovascular, Microvention, Q’apel, Balt and Siemens Healthineers. Dr. Kellner receives grant support from Integra, Penumbra, Viz.AI, Siemens, Medtronic, Minnetronix, Longeviti, Irras, ICE Neurosystems, CVAID, Endostream, and Microtransponder; and has equity in Precision Recovery, Borealis, E8, Borvo, and Metis Innovative. Mr. Giordano and Dr. McCabe are full time employees of Minnetronix Medical. Dr. Lad is a Senior Medical Advisor, Minnetronix Medical. Dr. McCabe was the PI on National Institutes of Health SBIR Grant R44NS110247, which provided study funding.
: The Extracorporeal Filtration of Subarachnoid Hemorrhage Via Spinal Catheter Extension trial made use of a central institutional review board (IRB), Western IRB (now WCG) for overall approval, while coordinating with local site IRBs for site approval. All study participants were consented prior to participation in the trial.
: ClinicalTrials.gov: NCT03607825.
